John A. Lust

34.0k total citations · 5 hit papers
257 papers, 18.7k citations indexed

About

John A. Lust is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, John A. Lust has authored 257 papers receiving a total of 18.7k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Hematology, 143 papers in Molecular Biology and 90 papers in Oncology. Recurrent topics in John A. Lust's work include Multiple Myeloma Research and Treatments (153 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (73 papers) and Protein Degradation and Inhibitors (41 papers). John A. Lust is often cited by papers focused on Multiple Myeloma Research and Treatments (153 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (73 papers) and Protein Degradation and Inhibitors (41 papers). John A. Lust collaborates with scholars based in United States, Canada and Italy. John A. Lust's co-authors include Robert A. Kyle, Morie A. Gertz, Martha Q. Lacy, S. Vincent Rajkumar, Angela Dispenzieri, Philip R. Greipp, Thomas E. Witzig, Shaji Kumar, Rafaël Fonseca and Suzanne R. Hayman and has published in prestigious journals such as New England Journal of Medicine, Circulation and The Journal of Experimental Medicine.

In The Last Decade

John A. Lust

252 papers receiving 18.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved survival in multiple myeloma and the impact of novel therapies

2007 1.7k citations Shaji Kumar, S. Vincent Rajkumar et al. Blood profile →
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

2003 1.6k citations Robert A. Kyle, Morie A. Gertz et al. Mayo Clinic Proceedings profile →
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

2013 957 citations Shaji Kumar, Angela Dispenzieri et al. profile →
Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

2012 730 citations Shaji Kumar, Angela Dispenzieri et al. Journal of Clinical Oncology profile →
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

2004 639 citations Angela Dispenzieri, Morie A. Gertz et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by John A. Lust

Since Specialization

Citations

This map shows the geographic impact of John A. Lust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Lust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Lust more than expected).

Fields of papers citing papers by John A. Lust

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Lust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Lust. The network helps show where John A. Lust may publish in the future.

Co-authorship network of co-authors of John A. Lust

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Lust. A scholar is included among the top collaborators of John A. Lust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Lust. John A. Lust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Substratification of patients with newly diagnosed standard‐risk multiple myeloma 2019 ·British Journal of Haematology ·Moritz Binder, S. Vincent Rajkumar, Rhett P. Ketterling, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, Yi L. Hwa, Steven R. Zeldenrust, John A. Lust, Stephen J. Russell, Nelson Leung, Prashant Kapoor, Ronald S. Go, Wilson I. Gonsalves, Robert A. Kyle, Shaji Kumar	10
2	Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL) 2017 ·American Journal of Hematology ·Nidhi Tandon, Surbhi Sidana, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, David Dingli, Francis K. Buadi, Amie Fonder, Suzanne R. Hayman, Yi L. Hwa, Miriam Hobbs, Prashant Kapoor, Wilson I. Gonsalves, Nelson Leung, Ronald S. Go, John A. Lust, Stephen J. Russell, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar	6
3	Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma 2017 ·Blood Cancer Journal ·Moritz Binder, S. Vincent Rajkumar, Rhett P. Ketterling, Patricia T. Greipp, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, Yi L. Hwa, Stephen R. Zeldenrust, John A. Lust, Stephen J. Russell, Nelson Leung, Prashant Kapoor, Ronald S. Go, Wilson I. Gonsalves, Robert A. Kyle, Shaji Kumar	56
4	The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation 2015 ·Nephrology Dialysis Transplantation ·Nelson Leung, Shaji Kumar, Siobhán Glavey, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Prashant Kapoor, Steven R. Zeldenrust, Stephen J. Russell, John A. Lust, William J. Hogan, S. Vincent Rajkumar, Dennis A. Gastineau, Taxiarchis Kourelis, Yi Lin, Wilson I. Gonsalves, Ronald S. Go, Morie A. Gertz	22
5	Importance of Achieving Stringent Complete Response After Autologous Stem-Cell Transplantation in Multiple Myeloma 2013 ·Journal of Clinical Oncology ·Prashant Kapoor, Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, David Dingli, Stephen J. Russell, Suzanne R. Hayman, Thomas E. Witzig, John A. Lust, Nelson Leung, Yi Lin, Steven R. Zeldenrust, Arleigh McCurdy, Philip R. Greipp, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz	120
6	Therapeutic Strategies For Initial Treatment Of AL Amyloidosis: Implications Of Therapy and Response On Outcome 2013 ·Blood ·Angela Dispenzieri, Morie A. Gertz, (unknown), Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Nelson Leung, Arleigh McCurdy, Yi L. Hwa, (unknown), David Dingli, Prashant Kapoor, Steven R. Zeldenrust, John A. Lust, Stephen J. Russell, S. Vincent Rajkumar, Shaji Kumar	2
7	A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma 2011 ·British Journal of Haematology ·(unknown), Craig B. Reeder, Shaji Kumar, M. Q. Lacy, Donna Reece, Angela Dispenzieri, Morie A. Gertz, (unknown), Suzanne R. Hayman, (unknown), David Dingli, John A. Lust, Stephen J. Russell, Kristina Laumann, Joseph Mıkhael, P. Leif Bergsagel, Rafaël Fonseca, S. Vincent Rajkumar, A. Keith Stewart	35
8	Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score 2010 ·Mayo Clinic Proceedings ·Shaji Kumar, Morie A. Gertz, Martha Q. Lacy, David Dingli, Suzanne R. Hayman, Francis K. Buadi, (unknown), Steven R. Zeldenrust, Nelson Leung, Philip R. Greipp, John A. Lust, Stephen J. Russell, Robert A. Kyle, S. Vincent Rajkumar, Angela Dispenzieri	124
9	Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma 2009 ·Journal of Clinical Oncology ·Martha Q. Lacy, Suzanne R. Hayman, Morie A. Gertz, Angela Dispenzieri, Francis K. Buadi, Shaji Kumar, Philip R. Greipp, John A. Lust, Stephen J. Russell, David Dingli, Robert A. Kyle, Rafaël Fonseca, P. Leif Bergsagel, Vivek Roy, Joseph Mıkhael, A. Keith Stewart, Kristina Laumann, Jacob B. Allred, Sumithra J. Mandrekar, S. Vincent Rajkumar	226
10	Short Communication: Absence of Evidence of HTLV-3 and HTLV-4 in Patients with Large Granular Lymphocyte (LGL) Leukemia 2008 ·AIDS Research and Human Retroviruses ·Yen T. Duong, Hongwei Jia, John A. Lust, Albert García-Quintanilla, Amanda Tiffany, Walid Heneine, William M. Switzer	21
11	Intracardiac Thrombosis and Embolism in Patients With Cardiac Amyloidosis 2007 ·Circulation ·DaLi Feng, William D. Edwards, Jae K. Oh, Krishnaswamy Chandrasekaran, Martha Grogan, Matthew W. Martinez, (unknown), Deborah A. Hughes, John A. Lust, Allan S. Jaffe, Morie A. Gertz, Kyle W. Klarich	185
12	Intestinal Lymphangiectasia With Protein-Losing Enteropathy in Waldenstrom Macroglobulinemia 2007 ·Medicine ·Keith W. Pratz, David Dingli, Thomas C. Smyrk, John A. Lust	17
13	Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays 2006 ·Mayo Clinic Proceedings ·Jerry A. Katzmann, Angela Dispenzieri, Robert A. Kyle, Melissa R. Snyder, Matthew F. Plevak, Dirk R. Larson, Roshini S. Abraham, John A. Lust, L. Joseph Melton, S. Vincent Rajkumar	141
14	Clinical Course of Patients With Relapsed Multiple Myeloma 2004 ·Mayo Clinic Proceedings ·Shaji Kumar, Terry M. Therneau, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, S. Vincent Rajkumar, Rafaël Fonseca, Thomas E. Witzig, John A. Lust, Dirk R. Larson, Robert A. Kyle, Philip R. Greipp	266
15	Primary follicular mucinosis: Long-term follow-up of patients younger than 40 years with and without clonal T-cell receptor gene rearrangement 2002 ·Journal of the American Academy of Dermatology ·Holly Brown, Lawrence E. Gibson, Ramón M. Pujol, John A. Lust, Mark R. Pittelkow	54
16	Scleromyxedema: A Complete Response to Prednisone 1999 ·Mayo Clinic Proceedings ·Daniel Rayson, John A. Lust, Alan J. Duncan, (unknown)	18
17	Sequence, Expression and Function of an mRNA Encoding a Soluble Form of the Human Interleukin-6 Receptor (sIL-6R) 1995 ·Current topics in microbiology and immunology ·John A. Lust, Diane F. Jelinek, Kathleen A. Donovan, Lori Frederick, Brenda K. Huntley, (unknown), Nita J. Maihle	17
18	T-cell receptor gene rearrangement analysis: Cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders 1991 ·Journal of the American Academy of Dermatology ·Brian D. Zelickson, Margot S. Peters, Sigfrid A. Muller, Stephen N. Thibodeau, John A. Lust, (unknown), Mark R. Pittelkow	92
19	Marrow hypoplasia associated with a monoclonal CD8 large granular lymphocyte proliferation: reversal with cyclophosphamide and prednisone☆ 1989 ·The American Journal of Medicine ·John A. Lust, Louis Letendre, Stephen N. Thibodeau	2
20	Heterogeneity of natural killer cells in the mouse. 1981 ·The Journal of Experimental Medicine ·John A. Lust, Vinay Kumar, Robert C. Burton, S.P. Bartlett, Michael V. L. Bennett	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact